McGill researchers pioneer major breakthrough in DNA nanotechnology

McGill researchers pioneer major breakthrough in DNA nanotechnology
A team of McGill Chemistry Department researchers led by Dr. Hanadi Sleiman has achieved a major breakthrough in the development of nanotubes – tiny “magic bullets” that could one day deliver drugs to specific diseased cells.

Read more on News-Medical-Net

Caltech-led Team Provides Proof in Humans of RNA Interference Using Targeted Nanoparticles

Caltech-led Team Provides Proof in Humans of RNA Interference Using Targeted Nanoparticles
A Caltech-led team of researchers and clinicians has published the first proof that a targeted nanoparticleused as an experimental therapeutic and injected directly into a patient’s bloodstreamcan traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi). Moreover, the team provided the …

Read more on Caltech Today

Researchers provide proof in humans of RNA interference using targeted nanoparticles

Researchers provide proof in humans of RNA interference using targeted nanoparticles
A California Institute of Technology (Caltech)-led team of researchers and clinicians has published the first proof that a targeted nanoparticle — used as an experimental therapeutic and injected directly into a patient’s bloodstream — can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA …

Read more on PhysOrg

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer
A California Institute of Technology -led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient’s bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).

Read more on News-Medical-Net

Proof In Humans Of RNA Interference Using Targeted Nanoparticles

Proof In Humans Of RNA Interference Using Targeted Nanoparticles
Researchers unveil scientific results from siRNA Phase I clinical trial in cancer patientsA California Institute of Technology (Caltech)-led team of researchers and clinicians has published the first proof that a targeted nanoparticle—used as an experimental therapeutic and injected directly into a patient’s bloodstream—can traffic into tumors, deliver double-stranded small interfering RNAs …

Read more on redOrbit

« Previous Page — Next Page »